Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: Neurochemical and behavioural studies in the rat

Psychopharmacology

Volumn 166, Issue 2, 2003, Pages 188-194

  Wegener, Gregers ^a,b   Bandpey, Zhale ^a   Heiberg, Ida Louise ^a   Mørk, Arne ^c   Rosenberg, Raben ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c H LUNDBECK A S   (Denmark)

Author keywords

Augmentation; Citalopram; Forced swimming; Lithium; Microdialysis; Serotonin

Indexed keywords

CITALOPRAM; LITHIUM; SEROTONIN;

ANALYSIS OF VARIANCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG POTENTIATION; FORCED SWIMMING TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMOBILIZATION; LOCOMOTION; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD BEHAVIOR; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

EID: 0037337827     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1341-6     Document Type: Article

References (68)

1. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 70:187-192
2. Baptista TJ, Hernandez L, Burguera JL, Burguera M, Hoebel BG (1990) Chronic lithium administration enhances serotonin release in the lateral hypothalamus but not in the hippocampus in rats. A microdialysis study. J Neural Transm Gen Sect 82:31-41
3. Bauer M, Dopfmer S (1999) Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 19:427-434
4. Baumann P, Nil R, Souche A, Montaldi S, Baettig D, Lambert S, Uehlinger C, Kasas A, Amey M, Jonzier-Perey M (1996) A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation. J Clin Psychopharmacol 16:307-314
5. Bel N, Artigas F (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 229:101-103
6. Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245
7. Broderick P, Lynch V (1982) Behavioral and biochemical changes induced by lithium and 1-tryptophan in muricidal rats. Neuropharmacology 21:671-679
8. Cappeliez P, White N, Duhamel JR (1982) Effect of serotonin depletion induced by p-chloroamphetamine on changes in rats' activity levels-produced by lithium. Neuropsychobiology 8:129-134
9. Collard KJ, Roberts MH (1975) Proceedings: the effects of chronic lithium administration on the metabolism of 1-tryptophan in the rat forebrain. Br J Pharmacol 55:268P
10. Connor TJ, Kelly JP, Leonard BE (1997) Forced swim test-induced neurochemical, endocrine, and immune changes in the rat. Pharmacol Biochem Behav 58:961-967
11. Connor TJ, Kelliher P, Shen Y, Harkin A, Kelly JP, Leonard BE (2000) Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacol Biochem Behav 65:591-597
12. Corrodi H, Fuxe K, Hokfelt T, Schou M (1967) The effect of lithium on cerebral monoamine neurons. Psychopharmacology 11:345-353
13. De Montigny C (1994) Lithium addition in treatment-resistant depression. Int Clin Psychopharmacol 9:S231-S235
14. Detke MJ, Johnson J, Lucki I (1997) Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 5:107-112
15. Dufour H, Bouchacourt M, Thermoz P, Viala A, Phak Rop P, Gouezo F, Durand A, Hopfner Petersen HE (1987) Citalopram - a highly selective 5-HT uptake inhibitor - in the treatment of depressed patients. Int Clin Psychopharmacol 2:225-237
16. Fuller RW (1994) Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 55:163-167
17. Gorka Z, Wojtasik E, Kwiatek H, Maj J (1979) Action of serotonin mimetics in the behavioral despair test in rats. Commun Psychopharmacol 3:133-136
18. Grahame-Smith DG, Green AR (1974) The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition. Br J Pharmacol 52:19-26
19. Grof P (1998) Has the effectiveness of lithium changed? Impact of the variety of lithium's effects. Neuropsychopharmacology 19:183-188
20. Grove WM, Andreasen NC (1982) Simultaneous tests of many hypotheses in exploratory research. J Nerv Ment Dis 170:3-8
21. Haddjeri N, Szabo ST, De Montigny C, Blier P (2000) Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments. Neuropsychopharmacology 22:346-356
22. Hascoet M, Bourin M, Khimake S (1994) Additive effect of lithium and clonidine with 5-HT1A agonists in the forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 18:381-396
23. Ho AK, Loh HH, Craves F, Hitzemann RJ, Gershon S (1970) The effect of prolonged lithium treatment on the synthesis rate and turnover of monoamines in brain regions of rats. Eur J Pharmacol 10:72-78
24. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9[Suppl 1]:19-26
25. Invernizzi R, Bramante M, Samanin R (1994) Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors. Eur J Pharmacol 260:243-246
26. Iwata H, Okamoto H, Kuramoto I (1974) Effect of lithium on serum tryptophan and brain serotonin in rats. Jpn J Pharmacol 24:235-240
27. Jensen J, Thomsen K, Olesen OV (1976) Current determination of lithium-induced minimum sodium requirement in rats. Psychopharmacology 45:295-299
28. Jordan S, Kramer GL, Zukas PK, Petty F (1994) Previous stress increases in vivo biogenic amine response to swim stress. Neurochem Res 19:1521-1525
29. Karoum F, Korpi ER, Chuang LW, Linnoila M, Wyatt RJ (1986) The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes. Eur J Pharmacol 121:377-385
30. Katona CL (1988) Lithium augmentation in refractory depression. Psychiatr Dev 6:153-171
31. Kofman O, Patishi Y (1999) Interactions of lithium and drugs that affect signal transduction on behaviour in rats. Eur Neuropsychopharmacol 9:385-397
32. Lopez-Rubalcava C, Lucki I (2000) Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 22:191-199
33. Maes M, Meltzer HY (1995) The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 933-944
34. Maj J, Rogoz Z, Skuza G (1982) Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity. Eur J Pharmacol 81:287-292
35. Mandell AJ, Knapp S (1980) Asymmetry and mood, emergent properties of serotonin regulation: a mechanism of action of lithium. In: Cooper T, Gershon S, Kline NS, Schou M (eds) Lithium controversies and unresolved issues. Excerpta Medica, Amsterdam, pp 789-814
36. Massot O, Rousselle JC, Fillion MP, Januel D, Plantefol M, Fillion G (1999) 5-HT1B receptors: a novel target for lithium. Possible involvement in mood disorders. Neuropsychopharmacology 21:530-541
37. McEwen BS (1999) Stress and hippocampal plasticity. Annu Rev Neurosci 22:105-122
38. Mongeau R, Blier P, De Montigny C (1997) The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Rev 23:145-195
39. Mork A (1998) Effects of lithium treatment on extracellular serotonin levels in the dorsal hippocampus and wet-dog shakes in the rat. Eur Neuropsychopharmacol 8:267-272
40. Muraki I, Inoue T, Hashimoto S, Izumi T, Ito K, Koyama T (2001) Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex. J Neurochem 76:490-497
41. Nixon MK, Hascoet M, Bourin M, Colombel MC (1994) Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology 115:59-64
42. Öhman R, Spigset O (1993) Serotonin syndrome induced by fluvoxamine-lithium interaction. Pharmacopsychiatry 26:263-264
43. Okamoto Y, Motohasi N, Hayakawa H, Muraoka M, Yamawaki S (1996) Addition of lithium to chronic antidepressant treatment potentiates presynaptic serotonergic function without changes in serotonergic receptors in the rat cerebral cortex. Neuropsychobiology 33:17-20
44. Otero LM, Rubio MC (1986) Time-related response of central serotonergic function to lithium administration. Gen Pharmacol 17:333-337
45. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. 2nd edn. Academic Press, New York
46. Porsolt RD (1979) Animal model of depression. Biomedicine 30:139-140
47. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379-391
48. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201-210
49. Price LH, Heninger GR (1994) Lithium in the treatment of mood disorders. N Engl J Med 331:591-598
50. Price LH, Charney DS, Delgado PL, Heninger GR (1990) Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology 100:3-12
51. Rouillon F, Gorwood P (1998) The use of lithium to augment antidepressant medication. J Clin Psychiatry 59:S532-539
52. Sanchez C, Meier E (1997) Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology 129:197-205
53. Satoh H, Mori J, Shimomura K, Ono T, Kikuchi H (1984) Effect of zimeldine, a new antidepressant, on the forced swimming test in rats. Jpn J Pharmacol 35:471-473
54. Schou M (1991) Clinical aspects of lithium in psychiatry. In: Birch NJ (ed) Lithium and the cell: pharmacology and biochemistry. Academic Press, London, pp 1-6
55. Sharp T, Bramwell SR, Lambert P, Grahame Smith DG (1991) Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro. Neuropharmacology 30:977-984
56. Sheard MH, Aghajanian GK (1970) Neuronally activated metabolism of brain serotonin: effect of lithium. Life Sci 9:285-290
57. Smith DF (1975) Biogenic amines and the effect of short term lithium administration on open field activity in rats. Psychopharmacology 41:295-300
58. Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148:705-713
59. Thase ME, Howland RH, Friedman ES (1998) Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry 59[Suppl 5]:5-12
60. van Praag HM, Korf J, Dols LCW, Schut T (1972) A pilot study of the predictive value of probenecid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacology 25:14-21
61. Waldmeier PC (1990) Mechanisms of action of lithium in affective disorders: a status report. Pharmacol Toxicol 66[Suppl 3]:121-132
62. Wegener G, Linnet K, Rosenberg R, Mork A (2000) The effect of acute citalopram on extracellular 5-HT levels is not augmented by lithium: an in vivo microdialysis study. Brain Res 871:338-342
63. West HL, Mark GP, Hoebel BG (1991) Effects of conditioned taste aversion on extracellular serotonin in the lateral hypothalamus and hippocampus of freely moving rats. Brain Res 556:95-100
64. Willner P (1984) The validity of animal models of depression. Psychopharmacology 83:1-16
65. Willner P (1994) Animal models of depression. In: den Boer JA (ed) Handbook of depression and anxiety: a biological approach. Cambridge University Press, pp 291-316
66. Worrall EP, Moody JP, Peet M, Dick P, Smith A, Chambers C, Adams M, Naylor GJ (1979) Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry 135:255-262
67. Zall H, Therman PG, Myers JM (1968) Lithium carbonate: a clinical study. Am J Psychiatry 125:549-555
68. Zullino D, Baumann P (2001) Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors. Pharmacopsychiatry 34:119-127